Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Terahertz Metamaterials for Tumour Marker Concentration Identification

NCT04125524 is registered in ClinicalTrials.gov with Durham University as lead sponsor.

NCT NCT04125524
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04125524 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Terahertz Metamaterials for Tumour Marker Concentration Identification
Lead sponsor
Durham University
Phase
Observational
Overall status
Suspended
Start date
May 17, 2021
Completion date
October 1, 2025
Enrollment
90 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malignant tumour